We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$275M
AUM Growth
+$7.11M
Cap. Flow
+$3.53M
Cap. Flow %
1.28%
Top 10 Hldgs %
30.46%
Holding
75
New
–
Increased
32
Reduced
36
Closed
1

Top Buys

1
KDP icon
Keurig Dr Pepper
KDP
+$1.54M
2
CLB icon
Core Laboratories
CLB
+$1.33M
3
DLX icon
Deluxe
DLX
+$1.32M
4
SEIC icon
SEI Investments
SEIC
+$758K
5
GPN icon
Global Payments
GPN
+$645K

Top Sells

1
ABT icon
Abbott
ABT
+$1.65M
2
CSCO icon
Cisco
CSCO
+$1.44M
3
ALTR
Altera Corp
ALTR
+$658K
4
GILD icon
Gilead Sciences
GILD
+$519K
5
OXY icon
Occidental Petroleum
OXY
+$452K

Sector Composition

1 Technology 18.87%
2 Healthcare 16.29%
3 Consumer Discretionary 15.68%
4 Industrials 14.83%
5 Consumer Staples 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
26
Amgen
AMGN
$201B
$4.84M 1.76%
40,918
+4,887
+14% +$566K
CBRL icon
27
Cracker Barrel
CBRL
$1.14B
$4.62M 1.68%
46,438
+1,286
+3% +$126K
EV
28
DELISTED
Eaton Vance Corp.
EV
$4.59M 1.67%
121,593
-850
-0.7% -$31.4K
K
29
DELISTED
Kellanova
K
$4.22M 1.53%
68,437
-188
-0.3% -$11.8K
NVO
30
Novo Nordisk
NVO
$228B
$4.16M 1.51%
180,294
+7,582
+4% +$167K
CPRT icon
31
Copart
CPRT
$26.2B
$4.13M 1.5%
917,896
-1,400
-0.2% -$6.31K
ABBV icon
32
AbbVie
ABBV
$449B
$3.96M 1.44%
70,128
– –
CLB icon
33
Core Laboratories
CLB
$530M
$3.68M 1.33%
22,008
+7,461
+51% +$1.33M
DLX icon
34
Deluxe
DLX
$1.22B
$3.48M 1.26%
59,376
+24,174
+69% +$1.32M
DLTR icon
35
Dollar Tree
DLTR
$24.7B
$3.45M 1.25%
63,384
+2,567
+4% +$135K
COL
36
DELISTED
Rockwell Collins
COL
$3.44M 1.25%
43,969
-480
-1% -$37.7K
ALTR
37
DELISTED
Altera Corp
ALTR
$3.18M 1.16%
91,540
-19,473
-18% -$658K
CNI icon
38
Canadian National Railway
CNI
$77.8B
$3.14M 1.14%
48,276
+5,891
+14% +$350K
EXPD icon
39
Expeditors International
EXPD
$23.8B
$2.98M 1.08%
67,599
-140
-0.2% -$6.02K
DHR icon
40
Danaher
DHR
$145B
$2.85M 1.04%
53,961
-320
-0.6% -$16.4K
KDP icon
41
Keurig Dr Pepper
KDP
$42.7B
$2.81M 1.02%
48,047
+27,481
+134% +$1.54M
XOM icon
42
ExxonMobil
XOM
$605B
$2.77M 1%
27,473
-715
-3% -$72.1K
PDCO
43
DELISTED
Patterson Companies, Inc.
PDCO
$2.72M 0.99%
68,794
-150
-0.2% -$6.07K
KMB icon
44
Kimberly-Clark
KMB
$36.2B
$2.6M 0.94%
24,354
-104
-0.4% -$11.1K
IBM icon
45
IBM
IBM
$206B
$2.48M 0.9%
14,324
+418
+3% +$75.2K
LH icon
46
Labcorp
LH
$23.1B
$2.28M 0.83%
25,920
+62
+0.2% +$5.37K
TPR icon
47
Tapestry
TPR
$29.1B
$2.11M 0.77%
61,722
-470
-0.8% -$20.2K
LLY icon
48
Eli Lilly
LLY
$1.04T
$1.99M 0.72%
32,009
-100
-0.3% -$5.97K
TECH icon
49
Bio-Techne
TECH
$11.2B
$1.81M 0.66%
78,320
-800
-1% -$17.7K
GPN icon
50
Global Payments
GPN
$22B
$1.79M 0.65%
49,052
+18,746
+62% +$645K
1
2
3

Similar funds

AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
FCM
Fourpath Capital Management Oklahoma City, Oklahoma $697M AUM 29.98% 1-Year Est. Return
GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JLB & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, JLB & Associates held 75 positions worth $275M, up 2.6% from $268M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 1.3%. JLB & Associates opened no new positions and exited 1, leaving the 75-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • JLB & Associates added most to Keurig Dr Pepper in Q2 2014, an estimated $1.54M increase.
  • JLB & Associates's biggest Q2 2014 reduction was Abbott, cutting an estimated $1.65M.
  • JLB & Associates fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $393K.
  • JLB & Associates's ten largest holdings make up 30% of its $275M portfolio in Q2 2014.
  • JLB & Associates opened 0 new positions and closed 1 in Q2 2014.
  • JLB & Associates's portfolio value rose 2.6% quarter-over-quarter to $275M.

Based on JLB & Associates's 13F filing for Q2 2014, filed 11 Jul 2014.